FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1962555352> ?p ?o ?g. }

• W1962555352 endingPage "11" @default.
• W1962555352 startingPage "1" @default.
• W1962555352 abstract "Cox, S. R., Liao, S., Payne-Johnson, M., Zielinski, R. J., Stegemann, M. R. Population pharmacokinetics of mavacoxib in osteoarthritic dogs. J. vet. Pharmacol. Therap. 34, 1–11. Mavacoxib (Trocoxil™) is an oral long-acting COX-2 inhibitor approved for the treatment of osteoarthritis in dogs. Two field trials were conducted in client-owned dogs suffering from osteoarthritis, with dosages of 4 mg/kg body weight (BW) (Study 1) or 2 mg/kg BW (Study 2). Mavacoxib plasma concentrations were determined from trough blood samples and from blood samples collected at 4–10 months after the last dose. A one-compartment linear model was fitted to the concentration data (1317 concentration records from 286 patients), and parameters for oral clearance (Cl/F), apparent volume of distribution (Vd/F) and their between-subject variabilities (BSV) were estimated. Covariates were included in the model based on the outcomes of stepwise regression procedures. In the final model, the typical value of Cl/F was a function of BW, age and breed. German shepherds and Labrador retrievers were found to have 31% higher values of Cl/F than patients from different breeds with similar ages and BWs. The typical value of Vd/F was found to be dependent only on BW. The two field studies appeared to differ similarly with respect to Cl/F and Vd/F. The explanation for this difference is not known, but the difference was accounted for in the final model as a 23.9% lower bioavailability in Study 2. Mavacoxib exhibited relatively broad BSV in Cl/F and Vd/F, with coefficients of variation of 47% and 19%, respectively. The typical value for mavacoxib’s terminal elimination plasma half-life (t1/2) was 44 days, but a minority of patients (approximately 5%) had empirical Bayes estimates of t1/2 exceeding 80 days. Simulations with the model indicated that the majority of patients treated with mavacoxib 2 mg/kg will maintain trough plasma mavacoxib concentrations associated with efficacy. Results of the population pharmacokinetic analysis helped to reduce the dose from 4 to 2 mg/kg and thus increased the therapeutic index for this molecule." @default.
• W1962555352 created "2016-06-24" @default.
• W1962555352 creator A5016293005 @default.
• W1962555352 creator A5021568848 @default.
• W1962555352 creator A5030656469 @default.
• W1962555352 creator A5054149626 @default.
• W1962555352 creator A5056887296 @default.
• W1962555352 date "2011-01-10" @default.
• W1962555352 modified "2023-10-01" @default.
• W1962555352 title "Population pharmacokinetics of mavacoxib in osteoarthritic dogs" @default.
• W1962555352 cites W1513076951 @default.
• W1962555352 cites W1984189311 @default.
• W1962555352 cites W1994202365 @default.
• W1962555352 cites W2039796430 @default.
• W1962555352 cites W2054565825 @default.
• W1962555352 cites W2083668821 @default.
• W1962555352 cites W2120416054 @default.
• W1962555352 cites W2121850944 @default.
• W1962555352 cites W2131764590 @default.
• W1962555352 cites W2159543650 @default.
• W1962555352 cites W2159562550 @default.
• W1962555352 cites W2161446377 @default.
• W1962555352 doi "https://doi.org/10.1111/j.1365-2885.2010.01183.x" @default.
• W1962555352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21219337" @default.
• W1962555352 hasPublicationYear "2011" @default.
• W1962555352 type Work @default.
• W1962555352 sameAs 1962555352 @default.
• W1962555352 citedByCount "36" @default.
• W1962555352 countsByYear W19625553522012 @default.
• W1962555352 countsByYear W19625553522013 @default.
• W1962555352 countsByYear W19625553522014 @default.
• W1962555352 countsByYear W19625553522015 @default.
• W1962555352 countsByYear W19625553522017 @default.
• W1962555352 countsByYear W19625553522018 @default.
• W1962555352 countsByYear W19625553522019 @default.
• W1962555352 countsByYear W19625553522020 @default.
• W1962555352 countsByYear W19625553522021 @default.
• W1962555352 countsByYear W19625553522022 @default.
• W1962555352 countsByYear W19625553522023 @default.
• W1962555352 crossrefType "journal-article" @default.
• W1962555352 hasAuthorship W1962555352A5016293005 @default.
• W1962555352 hasAuthorship W1962555352A5021568848 @default.
• W1962555352 hasAuthorship W1962555352A5030656469 @default.
• W1962555352 hasAuthorship W1962555352A5054149626 @default.
• W1962555352 hasAuthorship W1962555352A5056887296 @default.
• W1962555352 hasConcept C112705442 @default.
• W1962555352 hasConcept C126322002 @default.
• W1962555352 hasConcept C139254425 @default.
• W1962555352 hasConcept C140793950 @default.
• W1962555352 hasConcept C142724271 @default.
• W1962555352 hasConcept C162156334 @default.
• W1962555352 hasConcept C181389837 @default.
• W1962555352 hasConcept C204787440 @default.
• W1962555352 hasConcept C2776164576 @default.
• W1962555352 hasConcept C2776482104 @default.
• W1962555352 hasConcept C2908647359 @default.
• W1962555352 hasConcept C71924100 @default.
• W1962555352 hasConcept C86803240 @default.
• W1962555352 hasConcept C98274493 @default.
• W1962555352 hasConcept C99454951 @default.
• W1962555352 hasConceptScore W1962555352C112705442 @default.
• W1962555352 hasConceptScore W1962555352C126322002 @default.
• W1962555352 hasConceptScore W1962555352C139254425 @default.
• W1962555352 hasConceptScore W1962555352C140793950 @default.
• W1962555352 hasConceptScore W1962555352C142724271 @default.
• W1962555352 hasConceptScore W1962555352C162156334 @default.
• W1962555352 hasConceptScore W1962555352C181389837 @default.
• W1962555352 hasConceptScore W1962555352C204787440 @default.
• W1962555352 hasConceptScore W1962555352C2776164576 @default.
• W1962555352 hasConceptScore W1962555352C2776482104 @default.
• W1962555352 hasConceptScore W1962555352C2908647359 @default.
• W1962555352 hasConceptScore W1962555352C71924100 @default.
• W1962555352 hasConceptScore W1962555352C86803240 @default.
• W1962555352 hasConceptScore W1962555352C98274493 @default.
• W1962555352 hasConceptScore W1962555352C99454951 @default.
• W1962555352 hasIssue "1" @default.
• W1962555352 hasLocation W19625553521 @default.
• W1962555352 hasLocation W19625553522 @default.
• W1962555352 hasOpenAccess W1962555352 @default.
• W1962555352 hasPrimaryLocation W19625553521 @default.
• W1962555352 hasRelatedWork W1991459690 @default.
• W1962555352 hasRelatedWork W2022148560 @default.
• W1962555352 hasRelatedWork W2025835115 @default.
• W1962555352 hasRelatedWork W2036370392 @default.
• W1962555352 hasRelatedWork W2047596343 @default.
• W1962555352 hasRelatedWork W2249138846 @default.
• W1962555352 hasRelatedWork W2351351947 @default.
• W1962555352 hasRelatedWork W2367999783 @default.
• W1962555352 hasRelatedWork W2460276390 @default.
• W1962555352 hasRelatedWork W2528915772 @default.
• W1962555352 hasVolume "34" @default.
• W1962555352 isParatext "false" @default.
• W1962555352 isRetracted "false" @default.
• W1962555352 magId "1962555352" @default.
• W1962555352 workType "article" @default.